Search
forResearch 10 of 1000+
- 484 FDA cleared devices produce inconsistent platelet-rich plasma product
- Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic data
- Photobiomodulation therapy for androgenetic alopecia: A clinician’s guide to home-use devices cleared by the Federal Drug Administration
- Low level laser therapy and hair regrowth: an evidence-based review
- A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- What to Look for in Red Light Therapy: A Product Guide Backed by Science
- 530 A clinical comparison of photobiomodulation devices for the treatment of alopecia in all skin types
- A response to “Inconsistent platelet-rich plasma product from the Food and Drug Administration cleared devices: A retrospective review of clinic data”
Community 10 of 75
- No more hair transplants - a new FDA-cleared fractional laser treatment called FoLix
- Just FYI, Here are pictures of 6 months results on Clascoterone 5%. Is it remarkable? No. But it seems likely to be FDA approved considering 1% is already available. This is a win, especially if you pair it with other treatments like Finasteride.
- New warning by FDA on topical finasteride
- Dutasteride would have been approved for AGA by the US FDA.
- Finasteride alternative close to fda approval in the US
- Peeps who arent able to get gains even after using fda approved meds
- Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?
- FDA Policy Shift Explained: What It Actually Means for PP405, VDPHL-01, Breezula and Hair Loss Drug Timelines
- There’s actually a quite good chance that next year, we might see a new treatment get FDA approval for the first time in nearly three decades.
- Good news for stem cells hair therapies - US federal judge: using patients' stem cells does NOT fall under FDA jurisdiction